Sarcosine-Based Glycine Transporter Type-1 (GlyT-1) Inhibitors Containing Pyridazine Moiety: A Further Search for Drugs with Potential to Influence Schizophrenia Negative Symptoms

By  

Current Pharmaceutical Design, Vol. 21, Iss. 17, 2015-05 ,pp. : 2291-2303

Bentham Science Publishers

Access to resources Recommend Favorite

Progress in the Preparation and Testing of Glycine Transporter Type-1 (GlyT1) Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 17, 2006-09 ,pp. : 1883-1896

Bentham Science Publishers

Access to resources Recommend Favorite

Recent progress in the drug discovery of non-peptidic BACE1 inhibitors

By Hamada Yoshio   Kiso Yoshiaki  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 4, 2009-04 ,pp. : 391-416

Informa Healthcare

Access to resources Recommend Favorite

Novel inhibitors of the type 1 transporter for glycine (GlyT1) as antipsychotic agents

By Lowe III John A  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 11, 2005-11 ,pp. : 1657-1662

Informa Healthcare

Access to resources Recommend Favorite

Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat

By Black Mark   Varty Geoffrey   Arad Michal   Barak Segev   Levie Amaya   Boulay Denis   Pichat Philippe   Griebel Guy   Weiner Ina  

Psychopharmacology, Vol. 202, Iss. 1-3, 2009-01 ,pp. : 385-396

Springer Publishing Company

Access to resources Recommend Favorite